PENN Entertainment, Inc. ("PENN" or the "Company") (Nasdaq: PENN) today announced a new corporate organizational structure ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

The new 40,000-square-foot senior center is on Welaunee Boulevard in the Canopy development. Leon County Commissioner Brian ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

ParticulaABU DHABI, United Arab Emirates, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Particula, the leading rating provider for ...

Aaron LaBerge, Chief Technology Officer and Head of Interactive, will assume responsibility for all enterprise IT functions ...

NAXS AB ( ($SE:NAXS) ) has shared an announcement. NAXS AB has repurchased 6,807 of its own shares on Nasdaq Stockholm between 15 and 19 December ...

Detailed price information for Ke Holdings Inc ADR (BEKE-N) from The Globe and Mail including charting and trades.

Essentra ( ($GB:ESNT) ) has shared an announcement. Essentra plc has reported that as of 31 December 2025 its issued share capital comprised ...

Gov. Spencer Cox and other officials launched a new initiative to help military veterans caught up in the legal system in ...

As medical weight loss continues to evolve in 2026, the landscape of GLP-1 therapies has reached a pivotal moment with ...